People on these threads have been consumed by the Imugene (IMU...

People on these threads have been consumed by the Imugene (IMU ASX) share price, which has been able to be directed by both short and long holders due to a lack of volume. From today onwards more and more people are hearing and coming to grips with the genius of Professor Yuman Fong and his revolutionary virus that only kills cancer, and all types of cancer, that being Vaxinia. Last week new groups of people heard of the virus for the first time through a webinar in which Professor Fong presented. This week countless individuals including stock brokers, sophisticated investors and fund managers discovered his oncolytic virus for the first time at the Bioshares Summit in Hobart. Indeed they learnt how the virus killed all cancers against the NCI 60.

To assume the volume flowing through the IMU share register is not going to increase from here on in is a misnomer. The price may vary from day to day but the daily volume is set to increase toward the end of 2023 as more people familiarise themselves with Imugene's unique ability to extend, if not save the lives of cancer patients. Where there is demand there is volume. And where there is volume more often than not share prices rise over time. I would not discount the fact that as more and more people hear of Professor Fong and Vaxinia, unlike the protagonists permeating through these threads, more and more people are going to believe him. World renowned cancer researchers and surgeons of his ilk don't come around every day, if at all. Professor Fong's 33rd virus is set to take centre stage, and the world is still yet to wake up to it.




Opinions only